CStone Pharmaceuticals (2616.HK) Q3 2024 Earnings

23AugConfirmed
Q1 2024
Q3 2024
-0.14
-0.09
-0.04
0.01

Details

Expected EPS
-0.10724452720000001
Actual EPS
0.01072445272
Surprise EPS
0.12
Surprise Percent
+110%

Description

CStone Pharmaceuticals (2616.HK) has reported earnings of 0.01072445272 per share for Q3 2024.

0 Comments

Share your thoughts